Bristol Myers Squibb Receives European Commission Approval for Opdivo® in Combination with Cabometyx® as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma Biotech Investing
Merck Expands Safer Childbirth Cities Initiative to 20th Community-Led Project Advancing Maternal Health Equity During Black Maternal Health Week Pharmaceutical Investing
Knight to Present at the 2021 Bloom Burton & Co. Healthcare Virtual Investor Conference Medical Device Investing
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer Biotech Investing
Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 In Dry Eye Disease Associated With Meibomian Gland Dysfunction Medical Device Investing
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
World's Fastest Marathoner Eliud Kipchoge Uses Abbott's Libre Sense at NN Mission Marathon Qualifier Race for the Olympic Games Medical Device Investing
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx Biotech Investing
Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet Pharmaceutical Investing
